You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Glycemic Excursions

Showing 1 - 25 of 3,048
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Time in Range Trial in Cairo (Dipeptidyl peptidase-4 inhibitors)

Completed
  • Time in Range
  • Dipeptidyl peptidase-4 inhibitors
  • Cairo, Egypt
    Nancy Elbarbary
Aug 26, 2023

Type 2 Diabetes Trial in New York (Carbohydrate-Last Meal Sequence, Carbohydrate-First Meal Sequence)

Recruiting
  • Type 2 Diabetes
  • Carbohydrate-Last Meal Sequence
  • Carbohydrate-First Meal Sequence
  • New York, New York
    Weill Cornell Medicine
Mar 26, 2022

Gastrointestinal Hormones Trial in Jinan (colonic infusion)

Not yet recruiting
  • Gastrointestinal Hormones
  • colonic infusion
  • Jinan, Shandong, China
    Qilu Hospital of Shandong University
Mar 21, 2022

Type 2 Diabetes Trial in Aurora, Charlottesville (Glycemic Excursion Minimization (GEM), Medication Management (MM))

Not yet recruiting
  • Type 2 Diabetes
  • Glycemic Excursion Minimization (GEM)
  • Medication Management (MM)
  • Aurora, Colorado
  • +1 more
Mar 1, 2023

Type2 Diabetes Trial in New York (Abbott Freestyle Libre Pro, LifeStyle)

Terminated
Has Results
  • Type2 Diabetes
  • Abbott Freestyle Libre Pro
  • LifeStyle
  • New York, New York
    New York University School of Medicine
Aug 31, 2020

Type 1 Diabetes With Hypoglycemia Trial in Atlanta (Glucagon, Insulin)

Completed
  • Type 1 Diabetes Mellitus With Hypoglycemia
  • Atlanta, Georgia
    Atlanta Diabetes Associates
Jan 14, 2021

Diabetes Trial (CGM system with glucose alerts on, CGM system with glucose alerts off)

Not yet recruiting
  • Diabetes Mellitus
  • CGM system with glucose alerts on
  • CGM system with glucose alerts off
  • (no location specified)
Jul 11, 2023

Diabetes, Type 2 Trial in Kuala Lumpur, Seremban, Bangkok (Diabetes-Specific Formula, Standard Of Care)

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • Diabetes-Specific Formula
  • Standard Of Care
  • Kuala Lumpur, Malaysia
  • +4 more
Sep 27, 2022

Blood Glucose Variability in Type 2 Diabetes Mellitus and

Recruiting
  • COVID-19 Pneumonia
  • Type2diabetes
  • Glucose variability
  • Jinan, Shandong, China
    Qilu hospital of shandong university
Nov 24, 2023

Pancreatogenic Type 3C Diabetes Trial in Aalborg (Continuous glucose monitoring)

Recruiting
  • Pancreatogenic Type 3C Diabetes Mellitus
  • Continuous glucose monitoring
  • Aalborg, Denmark
    Department of Gastroenterology, Aalborg Hospital
Sep 19, 2022

Gestational Diabetes Trial in Tübingen (Diet Modification Group, Regular Diet Group)

Recruiting
  • Gestational Diabetes
  • Diet Modification Group
  • Regular Diet Group
  • Tübingen, Germany
    University of Tuebingen, Department of Internal Medicine IV
Mar 25, 2022

Type1 Diabetes Trial in Chandigarh (Medtronic Guardian Connect Sensor 3, Abott Freestyle Libre Sensor, Self blood Glucose

Not yet recruiting
  • Type1 Diabetes Mellitus
  • Medtronic Guardian Connect Sensor 3
  • +2 more
  • Chandigarh, India
    Post Graduate Institute of Medical Education and Research
Jun 28, 2023

Type2Diabetes Trial (YesMdiet, NoMdiet)

Not yet recruiting
  • Type2Diabetes
  • YesMdiet
  • NoMdiet
  • (no location specified)
Mar 22, 2022

Pancreatic Imaging Correlates in Cystic Fibrosis

Completed
  • Cystic Fibrosis
  • +4 more
  • Frequently Sampled Oral Glucose Tolerance Test and CGM
  • MRI Pancreas and Liver
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center
May 16, 2022

Anti-Inflammatory Effects of Time-Restricted Feeding

Recruiting
  • Psoriasis
  • Systemic Inflammation
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Oct 13, 2022

    Type 1 Diabetes Trial in New Haven (Very Low Carbohydrate Diet)

    Completed
    • Type 1 Diabetes
    • Very Low Carbohydrate Diet
    • New Haven, Connecticut
      Yale-New Haven Hospital
    Oct 31, 2022

    Hypoglycemia Trial in Boston (Dexcom continuous glucose monitor and activity monitor)

    Recruiting
    • Hypoglycemia
    • Dexcom continuous glucose monitor and activity monitor
    • Boston, Massachusetts
      Joslin Diabetes Center
    Apr 6, 2022

    Pediatric Obesity, Meal Timing Trial in Los Angeles (Meal-timing)

    Recruiting
    • Pediatric Obesity
    • Meal Timing
    • Meal-timing
    • Los Angeles, California
      Children's Hospital Los Angeles
    Nov 14, 2022

    Type 1 Diabetes Trial in Belgium (Dexcom G6 CGM)

    Completed
    • Type 1 Diabetes Mellitus
    • Dexcom G6 CGM
    • Aalst, Belgium
    • +5 more
    Dec 20, 2022

    Type 2 Diabetes Trial in Changsha (metformin+empagliflozin+insulin glargine, IDegLira, premixed insulin analogues)

    Recruiting
    • Type 2 Diabetes Mellitus
    • metformin+empagliflozin+insulin glargine
    • +2 more
    • Changsha, Hunan, China
      Xiangya Hospital of Central South University
    Sep 15, 2022

    Type1diabetes Trial in Naples (Insulin therapy adjustment, Nutritional adjustment, Combination of stategies)

    Enrolling by invitation
    • Type1diabetes
    • Insulin therapy adjustment
    • +2 more
    • Naples, Italy
      Federico II University Hospital
    Jun 30, 2023

    Gestational Diabetes in Pregnancy Trial in Baton Rouge (Blinded CGM)

    Recruiting
    • Gestational Diabetes Mellitus in Pregnancy
    • Blinded CGM
    • Baton Rouge, Louisiana
      Woman's Hospital
    Jan 30, 2023

    Type 2 Diabetes Trial in New York (Standardized, Usual Care Control (UCC), Personalized Guidance to Minimize Postprandial

    Recruiting
    • Type 2 Diabetes
    • Standardized
    • +2 more
    • New York, New York
      NYU Langone Health
    May 3, 2022

    Type1diabetes Trial in Renton (CGMIS (Continuous Glucose Monitoring Infusion Set))

    Recruiting
    • Type1diabetes
    • CGMIS (Continuous Glucose Monitoring Infusion Set)
    • Renton, Washington
      Rainier Clinical Research Center
    Sep 28, 2022

    Type1 Diabetes Trial in Sweden (Ixekizumab, Placebo)

    Recruiting
    • Type1 Diabetes Mellitus
    • Borås, Sweden
    • +17 more
    Dec 5, 2022